Development of a succinyl CoA:3-ketoacid CoA transferase inhibitor selective for peripheral tissues that improves glycemia in obesity.
Saved in:
| Title: | Development of a succinyl CoA:3-ketoacid CoA transferase inhibitor selective for peripheral tissues that improves glycemia in obesity. |
|---|---|
| Authors: | Tabatabaei Dakhili SA; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada., Yang K; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada., Al Nebaihi H; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada., Greenwell AA; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada., Wuest M; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada.; Cancer Research Institute of Northern Alberta, University of Alberta, Edmonton, AB T6G 2E1, Canada., Woodfield J; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada.; Cancer Research Institute of Northern Alberta, University of Alberta, Edmonton, AB T6G 2E1, Canada., Farraj RA; Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada., Saed CT; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada., Chan JSF; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada., Bhat RK; Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada., Mangra-Bala IA; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada., Shafaati T; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada., Gopal K; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada., Eaton F; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada., Ferrari SR; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada., Wagg CS; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada., Capozzi ME; Duke Molecular Physiology Institute, Duke University, Durham, NC 27701, USA., Campbell JE; Duke Molecular Physiology Institute, Duke University, Durham, NC 27701, USA., Overduin M; Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada., Velazquez-Martinez CA; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada., Glover JNM; Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada., Wuest F; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada.; Cancer Research Institute of Northern Alberta, University of Alberta, Edmonton, AB T6G 2E1, Canada., Brocks DR; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada., Ussher JR; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada. |
| Source: | IScience [iScience] 2025 Apr 03; Vol. 28 (5), pp. 112336. Date of Electronic Publication: 2025 Apr 03 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 40454095 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Development of a succinyl CoA:3-ketoacid CoA transferase inhibitor selective for peripheral tissues that improves glycemia in obesity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tabatabaei+Dakhili+SA%22">Tabatabaei Dakhili SA</searchLink>; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada.<br /><searchLink fieldCode="AU" term="%22Yang+K%22">Yang K</searchLink>; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada.<br /><searchLink fieldCode="AU" term="%22Al+Nebaihi+H%22">Al Nebaihi H</searchLink>; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.<br /><searchLink fieldCode="AU" term="%22Greenwell+AA%22">Greenwell AA</searchLink>; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada.<br /><searchLink fieldCode="AU" term="%22Wuest+M%22">Wuest M</searchLink>; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada.; Cancer Research Institute of Northern Alberta, University of Alberta, Edmonton, AB T6G 2E1, Canada.<br /><searchLink fieldCode="AU" term="%22Woodfield+J%22">Woodfield J</searchLink>; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada.; Cancer Research Institute of Northern Alberta, University of Alberta, Edmonton, AB T6G 2E1, Canada.<br /><searchLink fieldCode="AU" term="%22Farraj+RA%22">Farraj RA</searchLink>; Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada.<br /><searchLink fieldCode="AU" term="%22Saed+CT%22">Saed CT</searchLink>; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada.<br /><searchLink fieldCode="AU" term="%22Chan+JSF%22">Chan JSF</searchLink>; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada.<br /><searchLink fieldCode="AU" term="%22Bhat+RK%22">Bhat RK</searchLink>; Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada.<br /><searchLink fieldCode="AU" term="%22Mangra-Bala+IA%22">Mangra-Bala IA</searchLink>; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada.<br /><searchLink fieldCode="AU" term="%22Shafaati+T%22">Shafaati T</searchLink>; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada.<br /><searchLink fieldCode="AU" term="%22Gopal+K%22">Gopal K</searchLink>; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada.<br /><searchLink fieldCode="AU" term="%22Eaton+F%22">Eaton F</searchLink>; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada.<br /><searchLink fieldCode="AU" term="%22Ferrari+SR%22">Ferrari SR</searchLink>; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada.<br /><searchLink fieldCode="AU" term="%22Wagg+CS%22">Wagg CS</searchLink>; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada.<br /><searchLink fieldCode="AU" term="%22Capozzi+ME%22">Capozzi ME</searchLink>; Duke Molecular Physiology Institute, Duke University, Durham, NC 27701, USA.<br /><searchLink fieldCode="AU" term="%22Campbell+JE%22">Campbell JE</searchLink>; Duke Molecular Physiology Institute, Duke University, Durham, NC 27701, USA.<br /><searchLink fieldCode="AU" term="%22Overduin+M%22">Overduin M</searchLink>; Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada.<br /><searchLink fieldCode="AU" term="%22Velazquez-Martinez+CA%22">Velazquez-Martinez CA</searchLink>; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.<br /><searchLink fieldCode="AU" term="%22Glover+JNM%22">Glover JNM</searchLink>; Department of Biochemistry, University of Alberta, Edmonton, AB T6G 2H7, Canada.<br /><searchLink fieldCode="AU" term="%22Wuest+F%22">Wuest F</searchLink>; Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB T6G 1Z2, Canada.; Cancer Research Institute of Northern Alberta, University of Alberta, Edmonton, AB T6G 2E1, Canada.<br /><searchLink fieldCode="AU" term="%22Brocks+DR%22">Brocks DR</searchLink>; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.<br /><searchLink fieldCode="AU" term="%22Ussher+JR%22">Ussher JR</searchLink>; Faculty of Pharmacy and Pharmaceutical Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.; Alberta Diabetes Institute, University of Alberta, Edmonton, AB T6G 2E1, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101724038%22">IScience</searchLink> [iScience] 2025 Apr 03; Vol. 28 (5), pp. 112336. <i>Date of Electronic Publication: </i>2025 Apr 03 (<i>Print Publication: </i>2025). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101724038 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-0042 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225890042%22">25890042 </searchLink><i>NLM ISO Abbreviation: </i>iScience <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40454095 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.isci.2025.112336 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 112336 Titles: – TitleFull: Development of a succinyl CoA:3-ketoacid CoA transferase inhibitor selective for peripheral tissues that improves glycemia in obesity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tabatabaei Dakhili SA – PersonEntity: Name: NameFull: Yang K – PersonEntity: Name: NameFull: Al Nebaihi H – PersonEntity: Name: NameFull: Greenwell AA – PersonEntity: Name: NameFull: Wuest M – PersonEntity: Name: NameFull: Woodfield J – PersonEntity: Name: NameFull: Farraj RA – PersonEntity: Name: NameFull: Saed CT – PersonEntity: Name: NameFull: Chan JSF – PersonEntity: Name: NameFull: Bhat RK – PersonEntity: Name: NameFull: Mangra-Bala IA – PersonEntity: Name: NameFull: Shafaati T – PersonEntity: Name: NameFull: Gopal K – PersonEntity: Name: NameFull: Eaton F – PersonEntity: Name: NameFull: Ferrari SR – PersonEntity: Name: NameFull: Wagg CS – PersonEntity: Name: NameFull: Capozzi ME – PersonEntity: Name: NameFull: Campbell JE – PersonEntity: Name: NameFull: Overduin M – PersonEntity: Name: NameFull: Velazquez-Martinez CA – PersonEntity: Name: NameFull: Glover JNM – PersonEntity: Name: NameFull: Wuest F – PersonEntity: Name: NameFull: Brocks DR – PersonEntity: Name: NameFull: Ussher JR IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 04 Text: 2025 Apr 03 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 2589-0042 Numbering: – Type: volume Value: 28 – Type: issue Value: 5 Titles: – TitleFull: IScience Type: main |
| ResultId | 1 |